Shareholders who do not wish to continue holding their Shares and trade on the SEHK may elect to have all or some of their Shares cancelled by the Company pursuant to the Selective Capital Reduction at a Cancellation Price of
S$0.30 in cash per Participating Share (which, at the Latest Exchange Rate, represents HK$1.8387 per Participating Share). The Cancellation Price is final and will not be further increased or revised.
Note that this is not an exit offer. It's transferring the company's trading to SEHK. Currently, CAH is trading above HK$2 and closes at 2.01 in latest trade. This equates to S$0.327 at current exchange rate. This explains why the share is trading at n above S$0.30 (now, 20.5 mil vol on queue to buy) in SGX.
I feel there are people who intends to convert to the HK exchange and continue to invest in this company. Anyway, it's still a decent company who has consistently performed and give dividends, besides its enormous growth potential. The latter being the emphasis on healthcare requirements by the new leadership. Look at how they handled the H7N9 issue & the dead pigs problem. Think CAH can lead in these areas of healthcare research in animals.
Anyway, the stock has run up to H$K2.17 now, ab S$0.354. This is 18% higher than the cancellation price. I'm thinking of converting to HK shares. Anyone with good advice. Thanks.
I agree with kiasu. No sell. The stock will reach SGD cents 50 cents by end of the year. For a little paper work, best to transfer stock to hongkong. Worth the effort!
The stock has been trading at around 33 sgd cents on the hongkong exchange for the past 1 month!
Singapore investors who sold out at 28-29 cents have provided arbitrage opportunity to those who can wait and hold and then move the stock to hk.
Tks Abb. Also not forgetting that we are calculating these at an all time high of the chinese yuan and HK$, which are both pegged to each other. These mean that the true value could be much higher in S$ terms. Regards.
NextInsight
a hub for serious investors
